Studies on the effect of the anti-phagocytic agent cytochalasin B on Leishmania-macrophage interaction

Related Experiment Videos

Insights

Mouse macrophages engulf Leishmania parasites through phagocytosis, not active penetration. Cytochalasin B inhibits this process, highlighting the role of phagocytosis in Leishmania infection.

Area of Science:

  • Immunology
  • Cell Biology
  • Parasitology

Background:

  • Leishmania species infect macrophages, the primary host cells.
  • The mechanism of Leishmania entry into macrophages is crucial for understanding infection dynamics.

Purpose of the Study:

  • To investigate the mechanism of Leishmania entry into mouse peritoneal exudate cells (PECs).
  • To determine the role of phagocytosis in Leishmania infection.
  • To assess the effect of cytochalasin B on Leishmania uptake by macrophages.

Main Methods:

  • Culturing mouse PECs on coverslips.
  • Infecting macrophages with promastigotes of Leishmania enriettii, L. donovani, and L. tropica.
  • Treating cells with cytochalasin B at various concentrations.
  • Quantifying infection rates by counting stained cells.

Main Results:

  • Macrophages showed high infection rates for L. enriettii (53.5%) and L. donovani (52.3%), and lower for L. tropica (11.7%).
  • Cytochalasin B did not affect uptake when added simultaneously with parasites.
  • Pre-treatment with cytochalasin B significantly reduced infection rates to 1-2%, indicating inhibition of phagocytosis.
  • Washing cytochalasin B-treated cells partially restored infection, suggesting phagocytosis is essential.

Conclusions:

  • Leishmania infection of mouse PECs occurs via phagocytosis, not active cell penetration.
  • Cytochalasin B's inhibitory effect confirms the dependence of parasite entry on active phagocytic processes.
  • Despite susceptibility to L. tropica infection, mouse PECs exhibit lower phagocytic efficiency for this species compared to L. donovani and L. enriettii.

Related Concept Videos